<DOC>
	<DOCNO>NCT02254889</DOCNO>
	<brief_summary>Endoscopic submucosal dissection ( ESD ) widely use local treatment gastric neoplasms . Although ESD-related complication bleed perforation report , data currently lack development pain , one common adverse event ESD . Therefore , present study , investigate incidence clinicopathologic risk factor pain ESD .</brief_summary>
	<brief_title>Pain After Endoscopic Submucosal Dissection</brief_title>
	<detailed_description>A prospective randomized control study conduct evaluate 156 patient gastric neoplasms treat ESD Gangnam Severance Hospital April 2011 December 2014 . All subject randomly assign treatment intravenous proton pump inhibitor ( PPI ) either ESD .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<criteria>patient undergo ESD gastric neoplasm ( 1 ) history acid suppressive medication within 1 week prior procedure ; ( 2 ) know gastrointestinal disorder , peptic ulcer disease , might impact epigastric pain assessment ; ( 3 ) current regular use pain medication ; ( 4 ) history upper gastrointestinal surgery ; ( 5 ) multiple lesion require ESD ; ( 6 ) perforation ESD ; ( 7 ) significant cardiovascular , renal , hepatic , neurotic , psychological disorder</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>